Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.45 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.40 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | CDK8 | P49336 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3838974 | 0.89 | ALDH1A1 (0.54) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL3839157 | 0.89 | ALDH1A1 (0.54) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL27443501 | 0.88 | MAPT (0.50) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL3838956 | 0.87 | SMN1; SMN2 (0.58) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL3899847 | 0.86 | MAOB (0.59) | MAOBMAPTALDH1A1EGFR | |
| SCHEMBL30633275 | 0.85 | MAOB (0.55) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL3840708 | 0.85 | MAOB (0.55) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL6289255 | 0.85 | SMN1; SMN2 (0.60) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL6290665 | 0.85 | SMN1; SMN2 (0.60) | MAOBMAPTMEN1MITFALDH1A1 | |
| SCHEMBL4569951 | 0.85 | SMN1; SMN2 (0.60) | MAOBMAPTMEN1MITFALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115084655-A | Electrolyte, preparation method thereof and lithium metal battery containing electrolyte | 蜂巢能源科技(无锡)有限公司 | 2022-09-20 | — | — | CN | claimed |
| EP-0351214-A1 | Anti-inflammatory aryl derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-01-17 | — | — | EP | claimed |
| CN-115863765-A | Electrolyte and battery comprising same | 蜂巢能源科技股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115084655-A | Electrolyte, preparation method thereof and lithium metal battery containing electrolyte | 蜂巢能源科技(无锡)有限公司 | 2022-09-20 | — | — | CN | disclosed |
| EP-3912977-A1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BioMarin Pharmaceutical Inc. (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-3046920-B1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARM INC (US) | 2021-08-04 | — | — | EP | disclosed |
| US-9796708-B2 | Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors | ABBVIE INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160229830-A1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARMACEUTICAL INC. | 2016-08-11 | — | — | US | disclosed |
| US-20160229830-A1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARMACEUTICAL INC. | 2016-08-11 | — | — | US | disclosed |
| US-20160060257-A1 | PYRROLO [2,3-B] PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2016-03-03 | — | — | US | disclosed |
| EP-2970278-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | AbbVie Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-0720598-A1 | PHENOXYPHENYL CYCLOPENTENYL HYDROXYUREAS | PFIZER INC. (US) | 1996-07-10 | — | — | EP | disclosed |
| EP-0657459-A1 | Thienothiazine derivates, process for their preparation and their use as anti-inflammatory and analgesic agents | Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. (AT) | 1995-06-14 | — | — | EP | disclosed |
| EP-0558563-B1 | ANTI-INFLAMMATORY COMPOUNDS | WELLCOME FOUND (GB) | 1995-03-29 | — | — | EP | disclosed |
| WO-1995005360-A1 | PHENOXYPHENYL CYCLOPENTENYL HYDROXYUREAS | PFIZER INC. (US) | 1995-02-23 | — | — | WO | disclosed |
| EP-0384594-B1 | Anti-inflammatory aryl derivatives | WELLCOME FOUND (GB) | 1993-10-27 | — | — | EP | disclosed |
| EP-0558563-A1 | ANTI-INFLAMMATORY COMPOUNDS. | WELLCOME FOUND (GB) | 1993-09-08 | — | — | EP | disclosed |
| WO-1992009567-A1 | ANTI-INFLAMMATORY COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| EP-0384594-A1 | Anti-inflammatory aryl derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-08-29 | — | — | EP | disclosed |
| EP-0351214-A1 | Anti-inflammatory aryl derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060257-A1 | PYRROLO [2,3-B] PYRIDINE CDK9 KINASE INHIBITORS | CDK9, CDK19, CDK3 | MAOB 918/4885MAPT 2806/4885MEN1 2578/4885 |
| US-20160229830-A1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | GBA1, UGCG, GBA2 | MAOB 989/4885MAPT 2871/4885MEN1 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.